Octreotide

Mimics somatostatin; inhibits GH, glucagon, insulin, and GI peptide secretion

• ·Colorectal Neuroendocrine Tumor G1
• ·Gastric Neuroendocrine Tumor G1
• ·Neuroendocrine Neoplasm
• ·Neuroendocrine Tumor
• ·Neuroendocrine Tumor G2

No curated interaction pairs are recorded for Octreotide. This is not a statement that none exist — check a full interaction reference before combining.

• Diarrhea
• Abdominal pain
• Nausea
• Gallstones (long-term)
• Hyperglycemia

Half-life

1.5-2 hours

Protein binding

65%

Not recorded for Octreotide. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.